A Phase 3/4, Multi-Center, Randomized, Double-Blind, Placebo Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Adult Subjects of Black Race with Systemic Lupus Erythematosus (SLE) Save

Date Added
April 23rd, 2013
PRO Number
Pro00024258
Researcher
James C. Oates
Keywords
Autoimmune disease, Lupus
Summary

EMBRACE is a study of belimumab, also known as BENLYSTA, to treat lupus in adult black women and men. This study is being conducted to see if belimumab works and is safe for black patients. Patients will receive either belimumab or placebo (no drug) once a month in clinic for a year, plus their regular lupus medicines. For more information, contact Abby Powell at 843-792-0549.

Institution
MUSC
Recruitment Contact
Abby Powell
843-792-0549
powab@musc.edu

Change_preferences

-- OR --

Create_login